<p>在今天发布的一份报告中，Canaccord Genuity 的 Madeleine Williams 维持了对 Alterity Therapeutics 的买入评级，目标价为 0.01 澳元。</p>
<h3>在 TipRanks Premium 上享受 50% 的折扣，放心投资</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
<p>根据 TipRanks，Williams 的平均回报率为 -11.9%，成功率为 18.18%。Williams 关注医疗保健行业，主要分析 Cogstate Ltd、Telix Pharmaceuticals 和 Syntara Limited 等股票。</p>
<p>目前对 Alterity Therapeutics 的分析师共识评级为持有。</p>

ATHE

<p>Canaccord Genuity 的 Madeleine Williams 对 Alterity Therapeutics (PRNAF) 维持买入评级，目标价为 0.01 澳元。Williams 负责医疗保健行业，平均回报率为-11.9%，成功率为 18.18%。目前，分析师对 Alterity Therapeutics 的共识评级为持有</p>

<p>In a report released today, Madeleine Williams from Canaccord Genuity maintained a Buy rating on Alterity Therapeutics, with a price target of A$0.01.</p>
<div class="lb-trans"><p>在今天发布的一份报告中，Canaccord Genuity 的 Madeleine Williams 维持了对 Alterity Therapeutics 的买入评级，目标价为 0.01 澳元。</p>
</div><h3>Claim 50% Off TipRanks Premium and Invest with Confidence</h3>
<div class="lb-trans"><h3>在 TipRanks Premium 上享受 50% 的折扣，放心投资</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
</div><p>According to TipRanks, Williams is an analyst with an average return of -11.9% and a 18.18% success rate. Williams covers the Healthcare sector, focusing on stocks such as Cogstate Ltd, Telix Pharmaceuticals, and Syntara Limited.</p>
<div class="lb-trans"><p>根据 TipRanks，Williams 的平均回报率为 -11.9%，成功率为 18.18%。Williams 关注医疗保健行业，主要分析 Cogstate Ltd、Telix Pharmaceuticals 和 Syntara Limited 等股票。</p>
</div><p>The analyst consensus on Alterity Therapeutics is currently a Hold rating.</p>
<div class="lb-trans"><p>目前对 Alterity Therapeutics 的分析师共识评级为持有。</p>
</div>

Canaccord Genuity 维持对 Alterity Therapeutics（PRNAF）的买入评级